Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human CHRM1 Antibodies:
anti-Rat (Rattus) CHRM1 Antibodies:
anti-Mouse (Murine) CHRM1 Antibodies:
Go to our pre-filtered search.
Human Polyclonal CHRM1 Primary Antibody for ELISA, WB - ABIN188571
Fiedler, Nathanson: The type I inositol 1,4,5-trisphosphate receptor interacts with protein 4.1N to mediate neurite formation through intracellular Ca waves. in Neuro-Signals 2011
Show all 2 Pubmed References
Human Polyclonal CHRM1 Primary Antibody for ICC, IF - ABIN4336771
Molina, Rodriguez-Diaz, Fachado, Jacques-Silva, Berggren, Caicedo: Control of insulin secretion by cholinergic signaling in the human pancreatic islet. in Diabetes 2014
results suggest that the cyclic ADP-ribose signaling pathway participates in the contraction of small coronary arterial smooth muscle and Ca(2 (show CA2 Antibodies)+) release induced by activation of M(1) muscarinic receptors
We find that, as in V1, most parvalbumin (show PVALB Antibodies) neurons in MT express m1 AChRs but, unlike in V1, it appears that so do most excitatory neurons.
The study was focused on the human mAChR1 receptor for which a presumably reliable model was generated using the congener mAChR3 as the template along with a second less reliable model based on the distant beta2-AR template. The second model was then utilized to produce the chimeras by combining the conformations of its Pro-containing helices (i.e., TM4 (show TPM4 Antibodies), TM5, TM6 and TM7 with 16 modeled chimeras).
Receptor Species-dependent Desensitization Controls KCNQ1 (show KCNQ1 Antibodies)/KCNE1 (show KCNE1 Antibodies) K+ Channels as Downstream Effectors of Gq Protein-coupled Receptors.(
There were no significant associations between CHRM1 SNPs and autonomic nervous system activity in patients with schizophrenia on high-dose antipsychotics.
this study highlights how the properties of affinity and cooperativity can be differentially modified on a common structural scaffold and identifies molecular features that can be exploited to tailor the development of M1 mAChR (show CHRM3 Antibodies)-targeting PAMs.
CHRM2 (show CHRM2 Antibodies) but not CHRM1 or CHRM3 (show CHRM3 Antibodies) polymorphisms are associated with asthma susceptibility in Mexican patients.
the levels were comparable for complexes containing GluR2 (show GRIA2 Antibodies), GluR3 (show GRIA3 Antibodies) and GluR4 (show GRIA4 Antibodies) as well as 5-HT1A (show HTR1A Antibodies). Moreover, the levels of complexes containing muscarinic AChR M1, NR1 (show GRIN1 Antibodies) and GluR1 (show GRIA1 Antibodies) were significantly increased in male patients with AD.
We show that BQCA potentiates agonist-induced beta-arrestin recruitment to M1 mAChRs.
In patients with schizophrenia, both cell body staining and elevated M1 muscarinic receptor (show CHRM5 Antibodies) reactivity correlated with higher symptom scores.
demonstrate that activation of M1 muscarinic acetylcholine receptor augments the restitution of epithelial barrier function in T84 cell monolayers after ethanol-induced epithelial injury, via ERK-dependent phosphorylation of focal adhesion kinase
A breakdown in gene promoter methylation control of CHRM1 expression contributes to the global pathophysiology of schizophrenia.
Results indicate that direct inhibition of acetylcholinesterase (show AChE Antibodies) activity and up-regulation of m1 muscarinic acetylcholine receptor (show CHRNB1 Antibodies) expression in the striatum might contribute to the beneficial effects of alpha-asarone on locomotor hyperactivity in Fmr1 (show FMR1 Antibodies) knock out mice.
The three receptor sets considered (mAChR (show CHRM3 Antibodies), AR and TrkB (show NTRK2 Antibodies) receptors) intervene in modulating the conditions of the competition between nerve endings.
The memory deficits in mouse prion (show PRNP Antibodies) disease were completely restored by treatment with benzyl quinolone carboxylic acid (BQCA) and benzoquinazoline-12 (BQZ-12), two highly selective positive allosteric modulators (PAMs) of M1 mAChRs. Furthermore, prolonged exposure to BQCA markedly extended the lifespan of diseased mice.
Data suggest that the inositol phosphate accumulation assay has utility for the evaluation of M1 muscarinic acetylcholine receptor (show CHRNB1 Antibodies) activators in vivo.
determining the phosphorylation status of the M1 mAChR (show CHRM3 Antibodies) at Ser (show SIGLEC1 Antibodies)(228) not only provides a means of establishing receptor activation following drug treatment both in vitro and in vivo but also allows for the mapping of the activation status of the M1 mAChR (show CHRM3 Antibodies) in the hippocampus
M1 Muscarinic Receptor (show CHRM5 Antibodies) Deficiency Attenuates Azoxymethane-Induced Chronic Liver Injury in Mice
High M1 muscarinic receptor (show CHRM5 Antibodies) expression is associated with acute liver injury.
This study demonistrated that Expression of m1-type muscarinic acetylcholine receptors by parvalbumin (show PVALB Antibodies)-immunoreactive neurons in the primary visual cortex
The mm (chi(1 (show GRIN3A Antibodies)) congruent with -60 degrees ; chi(2) congruent with -60 degrees ) and tp (chi(1 (show GRIN3A Antibodies)) congruent with 180 degrees ; chi(2) congruent with +60 degrees ) rotamers were identified as the likely conduction-catalyzing conformations of the AChR's selectivity-filter glutamates.
The results of this study suggested that M1-muscarinic receptors promote fear memory consolidation via phospholipase C (show PLC Antibodies) and the M-current.
The muscarinic cholinergic receptors belong to a larger family of G protein-coupled receptors. The functional diversity of these receptors is defined by the binding of acetylcholine and includes cellular responses such as adenylate cyclase inhibition, phosphoinositide degeneration, and potassium channel mediation. Muscarinic receptors influence many effects of acetylcholine in the central and peripheral nervous system. The muscarinic cholinergic receptor 1 is involved in mediation of vagally-induced bronchoconstriction and in the acid secretion of the gastrointestinal tract. The gene encoding this receptor is localized to 11q13.
muscarinic acetylcholine receptor M1
, muscarinic receptor
, cholinergic receptor, muscarinic 1
, acetylcholine receptor, muscarinic 1
, Cholinergic receptor, muscarin 1
, m1 muscarinic acetylcholine receptor protein
, AChR M1
, muscarinic acetylcholine receptor 1